Table 1.

Characteristics of patients

Characteristic	Cohort 1 N (%)	Cohort 2 N (%)	Cohort 3 N (%)
No. of patients, N	60	14	9
Sex
Male	42 (70 %)	8 (57.1 %)	6 (66.7 %)
Female	18 (30 %)	6 (42.9 %)	3 (33.3 %)
Age, median years (range)	54 (27–81)	59.5(40–76)	65 (42–82)
Tumor classification
Cholangiocarcinoma	10 (16.7 %)	0	2 (22.2 %)
Colon cancer	7 (11.7 %)	1 (7.1 %)	0
Gastric cancer	7 (11.7 %)	0	0
Lung cancer	11 (18.3 %)	4 (28.6 %)	2 (22.2 %)
Primary liver cancer	25 (41.7 %)	1 (7.1 %)	2 (22.2 %)
Other	0	8 (57.1 %)	3 (33.3 %)
TNM staging
Stage I	3 (5 %)	1 (7.1 %)	2 (22.2 %)
Stage II	4 (6.7 %)	0	1 (11.1 %)
Stage IIIA	12 (20 %)	2 (14.3 %)	1 (11.1 %)
Stage IIIB	2 (3.3 %)	0	0
Stage IIIC	9 (15 %)	4 (28.6 %)	1 (11.1 %)
Stage IV	27 (45 %)	6 (42.9 %)	3 (33.3 %)
Missing data	3 (5 %)	1 (7.1 %)	1 (11.1 %)
Adjuvant therapeutic strategies
Without	24 (40 %)	5 (35.7 %)	7 (77.8 %)
With	36 (60 %)	9 (64.3 %)	2 (22.2 %)
Chemotherapy	18 (30 %)	6 (42.9 %)	1 (11.1 %)
Radiation therapy	8 (13.3 %)	1 (7.1 %)	1 (11.1 %)
Physiotherapy	2 (3.3 %)	0	1 (11.1 %)
Interventional treatment	9 (15 %)	2 (14.3 %)	0
Molecular targeted therapy	2 (3.3 %)	1 (7.1 %)	0